These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2358203)

  • 1. Platelet abnormalities in patients with cystic fibrosis and obligate heterozygotes.
    Mikhailidis DP; Stead RJ; Barradas MA; Hodson ME; Batten JC; Dandona P
    Haematologica; 1990; 75(2):137-40. PubMed ID: 2358203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic fibrosis heterozygotes do not have increased platelet activation.
    Tarnow I; Michelson AD; Frelinger AL; Linden MD; Li Y; Fox ML; Barnard MR; O'Sullivan BP
    Thromb Res; 2007; 121(2):159-62. PubMed ID: 17532368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of alpha-tocopherol on platelet membrane function in cystic fibrosis.
    Davis PB; Hubbard VS; Dieckman L; Boat TF; Stern RC; Doershuk CF
    J Lab Clin Med; 1984 Aug; 104(2):203-12. PubMed ID: 6086795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet hyperaggregability in cystic fibrosis.
    Stead RJ; Barradas MA; Mikhailidis DP; Jeremy JY; Hodson ME; Batten JC; Dandona P
    Prostaglandins Leukot Med; 1987 Feb; 26(2):91-103. PubMed ID: 3470815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related abnormalities of circulating polyamines and diamine oxidase activity in cystic fibrosis heterozygotes and homozygotes.
    Baylin SB; Rosenstein BJ; Marton LJ; Lockwood DH
    Pediatr Res; 1980 Aug; 14(8):921-5. PubMed ID: 6775274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis.
    Hammana I; Malet A; Costa M; Brochiero E; Berthiaume Y; Potvin S; Chiasson JL; Coderre L; Rabasa-Lhoret R
    Diabetes Metab; 2007 Jun; 33(3):213-9. PubMed ID: 17418606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clopidogrel anti-platelet effect: an evaluation by optical aggregometry, impedance aggregometry, and the platelet function analyzer (PFA-100).
    Dyszkiewicz-Korpanty A; Olteanu H; Frenkel EP; Sarode R
    Platelets; 2007 Nov; 18(7):491-6. PubMed ID: 17852774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung disease severity, chronic inflammation, iron deficiency, and erythropoietin response in adults with cystic fibrosis.
    Fischer R; Simmerlein R; Huber RM; Schiffl H; Lang SM
    Pediatr Pulmonol; 2007 Dec; 42(12):1193-7. PubMed ID: 17948283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of a serum hemagglutinin (lectinlike factor) in cystic fibrosis homozygotes and heterozygotes.
    Lieberman J; Kaneshiro W; Costea NV
    J Lab Clin Med; 1981 May; 97(5):646-53. PubMed ID: 7217767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring aspirin treatment in patients with thrombocytosis: comparison of the platelet function analyzer (PFA)-100 with optical aggregometry.
    Tsantes AE; Mantzios G; Giannopoulou V; Tsirigotis P; Bonovas S; Rapti E; Mygiaki E; Kartasis Z; Sitaras NM; Dervenoulas J; Travlou A
    Thromb Res; 2008; 123(1):100-7. PubMed ID: 18430462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of acute, moderate ethanol consumption on human platelet aggregation in platelet-rich plasma and whole blood.
    Zhang QH; Das K; Siddiqui S; Myers AK
    Alcohol Clin Exp Res; 2000 Apr; 24(4):528-34. PubMed ID: 10798590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood platelet calcium content and aggregation behaviour in myeloproliferative disorders and secondary thrombocytosis.
    Mindner K; Ostermann G; Hochhaus A; Höche D; Till U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):461-4. PubMed ID: 2465953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic fibrosis. Carbohydrate metabolism in CF and in animal models for CF.
    Bardoń A
    Acta Paediatr Scand Suppl; 1987; 332():1-30. PubMed ID: 3474861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alpha-1-antitrypsin and cystic fibrosis (author's transl)].
    Pecau Y; Feigelson J; Feingold J
    Pathol Biol (Paris); 1980 Nov; 28(9):575-8. PubMed ID: 7003504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystic fibrosis. In vitro and in vivo studies on the biochemical background to the pathogenesis.
    Ceder O
    Acta Paediatr Scand Suppl; 1983; 309():1-47. PubMed ID: 6581681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of cystic fibrosis by means of particle electrophoresis test.
    Hein J; Knippel E; Schütt W; Lenschow U; Gülzow HU; Breuel K; Bauer I; Bittorf T; Brock J
    Acta Univ Carol Med (Praha); 1990; 36(1-4):62-4. PubMed ID: 2130720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribonuclease and its inhibitor in red blood cells in CF.
    Bardoń A; Ceder O; Kollberg H
    Acta Univ Carol Med (Praha); 1990; 36(1-4):73-4. PubMed ID: 2130725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro platelet aggregation defects in patients with myeloproliferative disorders and high platelet counts: are they laboratory artefacts?
    Grignani C; Noris P; Tinelli C; Barosi G; Balduini CL
    Platelets; 2009 Mar; 20(2):131-4. PubMed ID: 19235056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of platelet aggregation abnormalities in thrombocytosis after thrombocytopheresis.
    Fabris F; Belloni M; Casonato A; Randi M; Ongaro G; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):853-62. PubMed ID: 6176511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alpha-1-antitrypsin and cystic fibrosis (author's transl)].
    Pecau Y; Feigelson J; Feingold J
    Sem Hop; 1981 Sep 8-15; 57(29-32):1306-9. PubMed ID: 6269206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.